| Literature DB >> 35522527 |
Chang Soo Kim1, Dmitry Nevozhay1, Rebeca Romero Aburto1, Ashok Pehere1, Lan Pang2, Rebecca Dillard3, Ziqiu Wang3, Clayton Smith3, Kelsey Boitnott Mathieu1, Marie Zhang4, John D Hazle1, Robert C Bast2, Konstantin Sokolov1,5,6.
Abstract
Lipid-based formulations provide a nanotechnology platform that is widely used in a variety of biomedical applications because it has several advantageous properties including biocompatibility, reduced toxicity, relative ease of surface modifications, and the possibility for efficient loading of drugs, biologics, and nanoparticles. A combination of lipid-based formulations with magnetic nanoparticles such as iron oxide was shown to be highly advantageous in a growing number of applications including magnet-mediated drug delivery and image-guided therapy. Currently, lipid-based formulations are prepared by multistep protocols. Simplification of the current multistep procedures can lead to a number of important technological advantages including significantly decreased processing time, higher reaction yield, better product reproducibility, and improved quality. Here, we introduce a one-pot, single-step synthesis of drug-loaded magnetic multimicelle aggregates (MaMAs), which is based on controlled flow infusion of an iron oxide nanoparticle/lipid mixture into an aqueous drug solution under ultrasonication. Furthermore, we prepared molecular-targeted MaMAs by directional antibody conjugation through an Fc moiety using Cu-free click chemistry. Fluorescence imaging and quantification confirmed that antibody-conjugated MaMAs showed high cell-specific targeting that was enhanced by magnetic delivery.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35522527 PMCID: PMC9121875 DOI: 10.1021/acs.bioconjchem.2c00167
Source DB: PubMed Journal: Bioconjug Chem ISSN: 1043-1802 Impact factor: 6.069